Helicobacter pylori infection in Ontario: prevalence and risk factors.
BACKGROUND
Helicobacter pylori has been classified by the World Health Organization as a type I carcinogen. Nearly 50% of the world's population is estimated to be infected with H pylori. Prevalence patterns of the infection are different between developing and developed countries. The present study had two objectives - to estimate the prevalence of H pylori infection in Ontario, and to evaluate the relationship between the infection and various demographic characteristics and selected lifestyle factors.


METHODS
Ten microlitres of plasma were aliquoted from stored blood of 1306 men and women, 50 to 80 years of age, from Ontario. The blood samples belonged to control patients of a colorectal cancer population-based study group. Serological testing was used to detect H pylori infection; information was obtained on dietary intake and lifestyle habits, as well as past and present medical history, education, income, number of siblings, ethnicity and place of birth.


RESULTS
The overall weighted seroprevalence of H pylori was 23.1% (95% CI 17.7% to 29.5%), with men having higher infection rates (29.4%, 95% CI 21.1% to 39.3%) than women (14.9%, 95% CI 10.1% to 21.4%). Seroprevalence of the infection increased significantly with age and number of siblings. Increased risk was also associated with being nonwhite, being born outside of Canada and immigrating at 20 years of age or older. An inverse association with seroprevalence was found for education and alcohol consumption.


CONCLUSIONS
The prevalence of H pylori infection in Ontario is comparable with that of other developed countries. Age, sex, number of siblings, ethnicity, place of birth and age at immigration are among the factors associated with H pylori infection.
Naja
Farah
F
Cancer Care Ontario, Toronto, Canada.
Kreiger
Nancy
N
Sullivan
Terrence
T
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000428:Alcohol Drinking; D000907:Antibodies, Bacterial / Q000097:blood; D015331:Cohort Studies; D004522:Educational Status; D005247:Feeding Behavior; D005260:Female; D016481:Helicobacter Infections / Q000175:diagnosis / Q000453:epidemiology* / Q000276:immunology*; D016480:Helicobacter pylori / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009864:Ontario / Q000453:epidemiology; D011203:Poverty; D015995:Prevalence; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D017678:Sex Distribution; D035781:Siblings; D012959:Socioeconomic Factors; D011795:Surveys and Questionnaires
D000907:Antibodies, Bacterial
Chronic Dis Can. 2000;21(2):81-6
11007659
Am J Gastroenterol. 1997 Oct;92(10):1780-7
9382036
Gastroenterology. 1997 Dec;113(6 Suppl):S9-14
9394753
Scand J Gastroenterol. 2003 Mar;38(3):268-76
12737441
Aliment Pharmacol Ther. 2000 Dec;14(12):1605-11
11121908
Cesk Farm. 1992 Jul;41(4-5):162-5
1451195
Eur J Gastroenterol Hepatol. 1996 Apr;8(4):365-9
8781907
Am J Epidemiol. 1995 Oct 15;142(8):856-63
7572962
J Infect Dis. 2000 Apr;181(4):1359-63
10762567
J Clin Epidemiol. 2000 Feb;53(2):175-81
10729690
Int J Cancer. 2002 Feb 20;97(6):811-8
11857360
Clin Infect Dis. 2004 Jul 1;39(1):11-7
15206046
Aliment Pharmacol Ther. 1995;9 Suppl 2:33-9
8547526
Int J Epidemiol. 2002 Jun;31(3):624-31
12055165
Aliment Pharmacol Ther. 2003 Jun 15;17(12):1481-91
12823150
Ann Epidemiol. 2005 Sep;15(8):607-13
16118005
Gastroenterology. 1991 Jun;100(6):1495-501
2019355
J Clin Microbiol. 1991 Mar;29(3):642-4
2037687
Can J Gastroenterol. 2004 May;18(5):295-302
15152278
Dig Dis Sci. 1999 Apr;44(4):668-74
10219820
J Pediatr. 2000 Jun;136(6):744-8
10839870
BMJ. 1995 Dec 23-30;311(7021):1657-60
8541747
Microbes Infect. 2003 Jul;5(8):705-13
12814771
Helicobacter. 2002 Apr;7(2):76-85
11966865
J Gastroenterol Hepatol. 1998 May;13(5):505-10
9641649
Scand J Gastroenterol. 1996 Mar;31(3):229-32
8833351
Lancet. 1996 Jul 20;348(9021):150-4
8684154
Lancet. 2000 Jan 29;355(9201):358-62
10665555
Am J Gastroenterol. 2002 Nov;97(11):2750-5
12425543
J Gastroenterol Hepatol. 2000 Mar;15(3):271-6
10764027
J Infect Dis. 1996 Nov;174(5):1120-3
8896521
BMJ. 2001 Oct 20;323(7318):920-2
11668141
Intern Med J. 2003 Apr;33(4):163-7
12680981
Helicobacter. 2005;10 Suppl 1:14-20
16178966
IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
7715068
Emerg Infect Dis. 2003 Sep;9(9):1128-35
14519251
Epidemiology. 2001 Mar;12(2):209-14
11246582